The functionalized NPs demonstrated superior results (median time for onset of leukemia = 160 days) relative to the drug and to non-functionalized NPs (19–22 days), most probably because of the increased intracellular concentrations of daunorubicin present in the B220+/Mac1− cells. The gene discussed is PTPRC; the disease is leukemia.